Idiopathic pulmonary fibrosis trials in Bulgaria

5 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  A Phase IIb Study to Evaluate AZD8965 in Participants with Idiopathic Pulmonary Fibrosis (IPF)

  Where

  Haskovo, Plovdiv, Ruse, Sofia, Sofiya

  Age

  18 years and over

  People

  139 worldwide

  Run by

  AstraZeneca AB

  See details and how to join2025-525016-41-00 · EU 2025-525016-41-00
• Phase 2Taking people
  A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

  Where

  Haskovo, Sofiya

  Age

  40 years and over

  People

  120 worldwide

  Run by

  Rein Therapeutics

  See details and how to joinNCT06968845 · EU 2025-520715-13-00
• Phase 2Taking people
  A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.

  Where

  Haskovo, Plovdiv, Rousse, Sofia

  Age

  40 years and over

  People

  359 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT07652658
• Phase 2Taking people
  A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis

  Where

  Haskovo, Sofiya

  Age

  40 years and over

  People

  240 worldwide

  Run by

  Chiesi Farmaceutici S.p.A.

  See details and how to joinNCT07516951 · EU 2024-514246-37-00
• Phase 2Taking people
  Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis

  Where

  Pleven, Plovdiv, Sofiya

  Age

  40 years and over

  People

  165 worldwide

  Run by

  AbbVie

  See details and how to joinNCT07230288 · EU 2024-518013-25-00